NCT04265872 2026-02-12
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
Baylor Research Institute
Phase EARLY_PHASE1 Recruiting
Clinical Trials
5 trialsNCT04711824 2025-12-23
SOLARA
Hoosier Cancer Research Network
Phase 1/2 Recruiting
NCT06900647 2025-04-02
BOCIS
Sun Yat-sen University
Phase 1 Recruiting
NCT04303988 2024-07-18
A Phase II Study of Triple-negative Breast Cancer Brain Metastases.
Fudan University
Phase 2 Recruiting
NCT04159818 2022-03-22
TONIC-2
The Netherlands Cancer Institute
Phase 2 Recruiting